egtazic acid has been researched along with Lymphoma, T-Cell in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Davidson, D; Dong, Z; Kurosaki, T; Pérez-Quintero, LA; Swat, W; Veillette, A | 1 |
1 other study(ies) available for egtazic acid and Lymphoma, T-Cell
| Article | Year |
|---|---|
The adaptor SAP controls NK cell activation by regulating the enzymes Vav-1 and SHIP-1 and by enhancing conjugates with target cells.
Topics: Animals; Antigens, CD; Binding Sites; Calcium Signaling; Cell Adhesion; Cell Line, Tumor; CHO Cells; Cricetinae; Cricetulus; Cytotoxicity, Immunologic; Egtazic Acid; Inositol Polyphosphate 5-Phosphatases; Intracellular Signaling Peptides and Proteins; Killer Cells, Lymphokine-Activated; Lymphocyte Activation; Lymphoma, T-Cell; Melanoma, Experimental; Mice; Phosphatidylinositol-3,4,5-Trisphosphate 5-Phosphatases; Phospholipase C gamma; Phosphoric Monoester Hydrolases; Protein Structure, Tertiary; Proto-Oncogene Proteins c-fyn; Proto-Oncogene Proteins c-vav; Receptors, Cell Surface; Signaling Lymphocytic Activation Molecule Associated Protein; Signaling Lymphocytic Activation Molecule Family Member 1 | 2012 |